baxter
-
Biologics
Baxter Announces U.S. FDA Clearance of Altapore Shape Bioactive Bone Graft for Use in Surgery
July 9, 2020 DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced U.S. Food…
Read More » -
Hospitals
Baxter Announces U.S. FDA Clearance of New Bone Graft Substitute, Actifuse Flow
Deerfield, Ill. – September 6, 2018 Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced U.S.…
Read More » -
Baxter to acquire Synovis
Baxter International Inc. (NYSE:BAX) and Synovis Life Technologies, Inc. (NASDAQ:SYNO) today announced a definitive agreement for Baxter to acquire Synovis,…
Read More » -
Biologics
Ceremed sells Ostene to Baxter
Ceremed, Inc. (Los Angeles) announced today that it has entered into a definitive agreement to sell its Ostene® brand bone…
Read More » -
Baxter Acquires Apatech
It was announced today that Baxter has done something Stryker seemingly has been unable (or unwilling) to. They have entered…
Read More » -
Baxter and ApaTech Announce Definitive Agreement
DEERFIELD, Ill. & LONDON–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global, diversified healthcare company, and ApaTech, a private equity-backed, U.K.-based orthobiologic…
Read More »